Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt
Identifieur interne : 001B23 ( Main/Exploration ); précédent : 001B22; suivant : 001B24Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt
Auteurs : Philip J. Thompson [Australie] ; Neil L. Misso [Australie] ; John Woods [Australie]Source :
- Respirology [ 1323-7799 ] ; 2007-11.
Abstract
Abstract: Very severe asthma and local pulmonary steroid resistance causes major problems for patients, physicians and the health system at large. It usually results in multiple admissions to hospital and high morbidity. Omalizumab was used to treat such patients with success. However, in doing so, it raised a number of issues relating to the best methods of using this treatment in such patients.
Url:
DOI: 10.1111/j.1440-1843.2007.01017.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002365
- to stream Istex, to step Curation: 002365
- to stream Istex, to step Checkpoint: 000A06
- to stream Main, to step Merge: 001B34
- to stream Main, to step Curation: 001B23
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt</title>
<author><name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
</author>
<author><name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
</author>
<author><name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F30D2E183BDBBC35E40562F8BDF850AB2ECC0932</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1111/j.1440-1843.2007.01017.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7QGVFDV9-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002365</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002365</idno>
<idno type="wicri:Area/Istex/Curation">002365</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A06</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A06</idno>
<idno type="wicri:doubleKey">1323-7799:2007:Thompson P:omalizumab:xolair:in</idno>
<idno type="wicri:Area/Main/Merge">001B34</idno>
<idno type="wicri:Area/Main/Curation">001B23</idno>
<idno type="wicri:Area/Main/Exploration">001B23</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt</title>
<author><name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Lung Institute of Western Australia and Centre for Asthma, Allergy and Respiratory Research, The University of Western Australia, Perth, Western Australia</wicri:regionArea>
<wicri:noRegion>Western Australia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Respirology</title>
<title level="j" type="sub">The Clinical Management of Severe Asthma, Canberra, Australia</title>
<title level="j" type="alt">RESPIROLOGY</title>
<idno type="ISSN">1323-7799</idno>
<idno type="eISSN">1440-1843</idno>
<imprint><biblScope unit="vol">12</biblScope>
<biblScope unit="issue">s3</biblScope>
<biblScope unit="page" from="S29">S29</biblScope>
<biblScope unit="page" to="S34">S34</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2007-11">2007-11</date>
</imprint>
<idno type="ISSN">1323-7799</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1323-7799</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Very severe asthma and local pulmonary steroid resistance causes major problems for patients, physicians and the health system at large. It usually results in multiple admissions to hospital and high morbidity. Omalizumab was used to treat such patients with success. However, in doing so, it raised a number of issues relating to the best methods of using this treatment in such patients.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Thompson, Philip J" sort="Thompson, Philip J" uniqKey="Thompson P" first="Philip J." last="Thompson">Philip J. Thompson</name>
</noRegion>
<name sortKey="Misso, Neil L" sort="Misso, Neil L" uniqKey="Misso N" first="Neil L." last="Misso">Neil L. Misso</name>
<name sortKey="Woods, John" sort="Woods, John" uniqKey="Woods J" first="John" last="Woods">John Woods</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B23 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B23 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:F30D2E183BDBBC35E40562F8BDF850AB2ECC0932 |texte= Omalizumab (Xolair) in patients with steroid‐resistant asthma: Lessons to be learnt }}
This area was generated with Dilib version V0.6.33. |